Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PROF vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROF
Profound Medical Corp.

Medical - Devices

HealthcareNASDAQ • CA
Market Cap$262M
5Y Perf.-41.5%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+133.6%

PROF vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROF logoPROF
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$262M$160.44B
Revenue (TTM)$16M$10.58B
Net Income (TTM)$42M$2.98B
Gross Margin70.8%66.3%
Operating Margin-256.3%30.5%
Forward P/E5.1x43.7x
Total Debt$0.00$303M
Cash & Equiv.$3.37B

PROF vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROF
ISRG
StockMay 20May 26Return
Profound Medical Co… (PROF)10058.5-41.5%
Intuitive Surgical,… (ISRG)100233.6+133.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROF vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PROF leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Intuitive Surgical, Inc. is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
PROF
Profound Medical Corp.
The Growth Play

PROF carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 58.3%, EPS growth 231.8%, 3Y rev CAGR 34.1%
  • 58.3% revenue growth vs ISRG's 20.5%
  • Lower P/E (5.1x vs 43.7x)
Best for: growth exposure
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the clearest fit if your priority is income & stability and long-term compounding.

  • beta 1.02
  • 5.6% 10Y total return vs PROF's -25.6%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthPROF logoPROF58.3% revenue growth vs ISRG's 20.5%
ValuePROF logoPROFLower P/E (5.1x vs 43.7x)
Quality / MarginsPROF logoPROF262.9% margin vs ISRG's 28.2%
Stability / SafetyISRG logoISRGBeta 1.02 vs PROF's 1.61
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PROF logoPROF+45.6% vs ISRG's -14.8%
Efficiency (ROA)PROF logoPROF78.4% ROA vs ISRG's 14.8%

PROF vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PROFProfound Medical Corp.
FY 2025
Recurring - Non-Capital
60.4%$10M
Capital Equipment
39.6%$6M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

PROF vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGPROF

Income & Cash Flow (Last 12 Months)

Evenly matched — PROF and ISRG each lead in 3 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 657.4x PROF's $16M. Profitability is closely matched — net margins range from 2.6% (PROF) to 28.2% (ISRG). On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$16M$10.6B
EBITDAEarnings before interest/tax-$33M$3.8B
Net IncomeAfter-tax profit$42M$3.0B
Free Cash FlowCash after capex-$38M$2.8B
Gross MarginGross profit ÷ Revenue+70.8%+66.3%
Operating MarginEBIT ÷ Revenue-2.6%+30.5%
Net MarginNet income ÷ Revenue+2.6%+28.2%
FCF MarginFCF ÷ Revenue-2.4%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+13.3%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+15.0%+18.8%
Evenly matched — PROF and ISRG each lead in 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — PROF and ISRG each lead in 1 of 2 comparable metrics.

At 5.1x trailing earnings, PROF trades at a 91% valuation discount to ISRG's 57.4x P/E.

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
Market CapShares × price$262M$160.4B
Enterprise ValueMkt cap + debt − cash$262M$157.4B
Trailing P/EPrice ÷ TTM EPS5.12x57.40x
Forward P/EPrice ÷ next-FY EPS est.43.67x
PEG RatioP/E ÷ EPS growth rate2.64x
EV / EBITDAEnterprise value multiple43.44x
Price / SalesMarket cap ÷ Revenue16.28x15.94x
Price / BookPrice ÷ Book value/share9.13x
Price / FCFMarket cap ÷ FCF64.42x
Evenly matched — PROF and ISRG each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

Evenly matched — PROF and ISRG each lead in 3 of 6 comparable metrics.

PROF delivers a 138.5% return on equity — every $100 of shareholder capital generates $139 in annual profit, vs $17 for ISRG. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs PROF's 4/9, reflecting solid financial health.

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+138.5%+16.9%
ROA (TTM)Return on assets+78.4%+14.8%
ROICReturn on invested capital+15.0%
ROCEReturn on capital employed-61.9%+16.5%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.02x
Net DebtTotal debt minus cash$0-$3.1B
Cash & Equiv.Liquid assets$3.4B
Total DebtShort + long-term debt$0$303M
Interest CoverageEBIT ÷ Interest expense
Evenly matched — PROF and ISRG each lead in 3 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $3,588 for PROF. Over the past 12 months, PROF leads with a +45.6% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs PROF's -19.3% — a key indicator of consistent wealth creation.

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-5.7%-19.6%
1-Year ReturnPast 12 months+45.6%-14.8%
3-Year ReturnCumulative with dividends-47.5%+49.0%
5-Year ReturnCumulative with dividends-64.1%+60.9%
10-Year ReturnCumulative with dividends-25.6%+556.9%
CAGR (3Y)Annualised 3-year return-19.3%+14.2%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — PROF and ISRG each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than PROF's 1.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PROF currently trades 80.7% from its 52-week high vs ISRG's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.61x1.02x
52-Week HighHighest price in past year$8.95$603.88
52-Week LowLowest price in past year$3.76$427.84
% of 52W HighCurrent price vs 52-week peak+80.7%+74.8%
RSI (14)Momentum oscillator 0–10061.142.2
Avg Volume (50D)Average daily shares traded213K1.8M
Evenly matched — PROF and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates PROF as "Buy" and ISRG as "Buy". Consensus price targets imply 66.2% upside for PROF (target: $12) vs 37.8% for ISRG (target: $623).

MetricPROF logoPROFProfound Medical …ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$12.00$622.60
# AnalystsCovering analysts755
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 1 of 6 categories — strongest in Total Returns. 4 categories are tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 1 of 6 categories
Loading custom metrics...

PROF vs ISRG: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is PROF or ISRG a better buy right now?

For growth investors, Profound Medical Corp.

(PROF) is the stronger pick with 58. 3% revenue growth year-over-year, versus 20. 5% for Intuitive Surgical, Inc. (ISRG). Profound Medical Corp. (PROF) offers the better valuation at 5. 1x trailing P/E, making it the more compelling value choice. Analysts rate Profound Medical Corp. (PROF) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROF or ISRG?

On trailing P/E, Profound Medical Corp.

(PROF) is the cheapest at 5. 1x versus Intuitive Surgical, Inc. at 57. 4x.

03

Which is the better long-term investment — PROF or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +60. 9%, compared to -64. 1% for Profound Medical Corp. (PROF). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus PROF's -25. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROF or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus Profound Medical Corp. 's 1. 61β — meaning PROF is approximately 58% more volatile than ISRG relative to the S&P 500.

05

Which is growing faster — PROF or ISRG?

By revenue growth (latest reported year), Profound Medical Corp.

(PROF) is pulling ahead at 58. 3% versus 20. 5% for Intuitive Surgical, Inc. (ISRG). On earnings-per-share growth, the picture is similar: Profound Medical Corp. grew EPS 231. 8% year-over-year, compared to 22. 6% for Intuitive Surgical, Inc.. Over a 3-year CAGR, PROF leads at 34. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROF or ISRG?

Profound Medical Corp.

(PROF) is the more profitable company, earning 262. 9% net margin versus 28. 4% for Intuitive Surgical, Inc. — meaning it keeps 262. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -256. 3% for PROF. At the gross margin level — before operating expenses — PROF leads at 70. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROF or ISRG more undervalued right now?

Analyst consensus price targets imply the most upside for PROF: 66.

2% to $12. 00.

08

Which pays a better dividend — PROF or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is PROF or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Profound Medical Corp. (PROF) carries a higher beta of 1. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +556. 9%, PROF: -25. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROF and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PROF

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 157%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PROF and ISRG on the metrics below

Revenue Growth>
%
(PROF: 13.3% · ISRG: 23.0%)
Net Margin>
%
(PROF: 262.9% · ISRG: 28.2%)
P/E Ratio<
x
(PROF: 5.1x · ISRG: 57.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.